William Blair initiates coverage of digital finance stocks

William Blair initiates coverage of digital finance stocks with an Outperform on SoFi, Affirm
SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the digital finance subsegment of fintech with an Outperform rating on the two stocks.
Sterling Infrastructure initiated with an Outperform at William Blair
William Blair last night initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating. Sterling’s “industry-leading” data
Cboe Global Markets initiated with a Market Perform at William Blair
William Blair initiated coverage of Cboe Global Markets (CBOE) with a Market Perform rating and no price target The firm does not expect multiple expansion for the shares as zero days to expiration options mature and the company’s derivatives revenue growth normalizes.
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and conservative guidance. The investment firm noted that after several "solid" quarters following a Q1 2024 miss and turnover in its sales force,
William Blair starts SoFi, Affirm with Outperform ratings
William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm
Affirm, SoFi Initiated At Outperform In Consumer Digital Financing
William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.
William Blair Boosts Earnings Estimates for LPL Financial
William Blair raised their Q4 2024 EPS estimates for LPL Financial in a report released on Monday, January 13th. William ...
24/7 Wall St5h
SoFi Technologies (SOFI) Price Prediction and Forecast 2025-2030
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
FierceBiotech2d
Neumora's dig into phase 3 depression data disappoints analysts
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
FY2025 EPS Estimates for MarketAxess Cut by William Blair
Equities research analysts at William Blair lowered their FY2025 earnings estimates for shares of MarketAxess in a research ...
Morningstar23h
William Blair Global Leaders I
William Blair Global Leaders Fund earns a Below Average Process Pillar rating. The process benefits from low costs across its parent firm's funds, whose fees rank in their respective category's ...
bovnews6h
Enovix Corp (ENVX) Posted -1180.22% Profit Margin Last Year—Can It Hold Up?
Enovix Corp (ENVX) stock saw a modest uptick, ending the day at $10.95 which represents a slight increase of $0.17 or 1.58% from the prior close of $10.78. The stock opened at $10.75 and touched a low ...
William Blair Predicts Zumiez’s Q4 Earnings (NASDAQ:ZUMZ)
Equities research analysts at William Blair dropped their Q4 2025 EPS estimates for Zumiez in a research report issued on ...